GALIMBERTI, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 20.249
EU - Europa 13.162
AS - Asia 12.325
SA - Sud America 1.693
Continente sconosciuto - Info sul continente non disponibili 997
AF - Africa 308
OC - Oceania 33
Totale 48.767
Nazione #
US - Stati Uniti d'America 19.138
IT - Italia 4.134
SG - Singapore 3.932
SE - Svezia 2.894
CN - Cina 2.390
VN - Vietnam 2.383
HK - Hong Kong 1.486
DE - Germania 1.483
BR - Brasile 1.275
RU - Federazione Russa 1.204
CA - Canada 870
IE - Irlanda 770
GB - Regno Unito 575
BD - Bangladesh 479
FR - Francia 448
UA - Ucraina 372
IN - India 365
FI - Finlandia 232
NL - Olanda 204
ID - Indonesia 203
KR - Corea 187
AT - Austria 185
TR - Turchia 139
ES - Italia 136
AR - Argentina 135
MX - Messico 133
JP - Giappone 119
IQ - Iraq 116
PL - Polonia 104
ZA - Sudafrica 85
BE - Belgio 74
PK - Pakistan 73
DK - Danimarca 72
SA - Arabia Saudita 71
PH - Filippine 60
VE - Venezuela 56
CH - Svizzera 55
EC - Ecuador 55
CO - Colombia 51
MA - Marocco 50
PY - Paraguay 37
EG - Egitto 36
LT - Lituania 36
UZ - Uzbekistan 34
MY - Malesia 32
AU - Australia 29
AE - Emirati Arabi Uniti 28
TN - Tunisia 27
UY - Uruguay 27
CL - Cile 26
GR - Grecia 26
JO - Giordania 26
CR - Costa Rica 25
KE - Kenya 25
ET - Etiopia 24
NP - Nepal 24
PT - Portogallo 23
CZ - Repubblica Ceca 21
JM - Giamaica 21
RO - Romania 21
AZ - Azerbaigian 19
IR - Iran 19
IL - Israele 18
PE - Perù 18
TH - Thailandia 18
DZ - Algeria 16
KZ - Kazakistan 14
AL - Albania 11
LB - Libano 11
OM - Oman 11
BG - Bulgaria 10
BO - Bolivia 10
HU - Ungheria 9
NI - Nicaragua 9
NO - Norvegia 9
PS - Palestinian Territory 9
RS - Serbia 9
HN - Honduras 8
HR - Croazia 8
TW - Taiwan 8
BY - Bielorussia 7
PA - Panama 7
SK - Slovacchia (Repubblica Slovacca) 7
TT - Trinidad e Tobago 7
AO - Angola 6
BH - Bahrain 6
DO - Repubblica Dominicana 6
SI - Slovenia 6
SY - Repubblica araba siriana 6
CI - Costa d'Avorio 5
EU - Europa 5
GT - Guatemala 5
LV - Lettonia 5
MD - Moldavia 5
SV - El Salvador 5
AM - Armenia 4
BW - Botswana 4
GA - Gabon 4
KW - Kuwait 4
NZ - Nuova Zelanda 4
Totale 47.693
Città #
Ann Arbor 2.645
Singapore 2.322
Ashburn 2.021
Stockholm 1.909
Hong Kong 1.413
San Jose 1.374
Milan 1.358
Frankfurt am Main 858
Fairfield 843
Chandler 826
Dublin 750
Woodbridge 722
Ho Chi Minh City 707
Houston 577
Hanoi 572
Toronto 569
New York 555
Wilmington 549
Los Angeles 477
Dallas 433
Santa Clara 402
Beijing 351
Seattle 337
Jacksonville 329
Hefei 318
Dearborn 307
Chicago 306
Cambridge 289
Princeton 249
Rome 230
The Dalles 217
Council Bluffs 191
Shanghai 168
Buffalo 166
Seoul 165
Lauterbourg 160
São Paulo 144
Boardman 143
Jakarta 137
Nanjing 134
Vienna 134
Moscow 133
Columbus 123
Orem 110
Helsinki 103
Altamura 100
Lawrence 95
Tokyo 88
Denver 86
London 83
Da Nang 82
Haiphong 77
Warsaw 77
Atlanta 76
Munich 76
Montreal 75
Brooklyn 63
Naples 62
Nuremberg 60
Turin 60
San Diego 58
Chennai 57
Lissone 56
Ottawa 56
Brussels 55
Dong Ket 55
Monza 54
Phoenix 54
San Francisco 53
Lachine 52
Figino 51
Biên Hòa 48
Florence 46
Baghdad 45
Bologna 45
Nanchang 45
Johannesburg 44
Poplar 42
Guangzhou 41
Hải Dương 41
Shenyang 41
Tianjin 41
Washington 41
Dhaka 40
Fremont 40
Zurich 39
Amsterdam 38
Falls Church 38
Ha Long 38
Jinan 38
Rio de Janeiro 38
Andover 37
Genoa 37
Lappeenranta 37
Manchester 37
Mexico City 36
Turku 36
Changsha 35
Quận Bình Thạnh 35
Coventry 34
Totale 29.740
Nome #
Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial 1.991
Reference Values of Ceruloplasmin across the Adult Age Range in a Large Italian Healthy Population 895
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 708
Thyroid Function Tests in Children and Adolescents with Trisomy 21: Definition of Syndrome-Specific Reference Ranges 499
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 495
Tracheostomy practice and timing in traumatic brain-injured patients: a CENTER-TBI study 490
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 463
The SIPI for measuring complexity in nursing care: Evaluation study 456
Ventilation practices in acute brain injured patients and association with outcomes: the VENTIBRAIN multicenter observational study 442
Effect of Oral Hydration on External Cephalic Version at Term 442
Carotid plaque echolucency increases the risk of stroke in carotid stenting: The imaging in carotid angioplasty and risk of stroke (ICAROS) study 437
Rendering the invisible visible: adding a molecular dimension to pathology with spatial omics 432
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 431
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 429
GNPAT rs11558492 is not a major modifier of iron status: Study of Italian hemochromatosis patients and blood donors 416
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 411
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 403
Use of Shear Wave Elastography in the Sonographic Triage of Thyroid Nodules: Feasibility Study in a Series of Lesions Already Selected for Fine Needle Aspiration 399
Basket trials in very rare diseases: are they feasible? 395
Comparison of tumor microenvironment in primary and paired metastatic ER+/HER2- breast cancers: results of a pilot study 388
BIVARIATE COPULA MODELS IN THE PRESENCE OF COMPLEX PATTERNS FOR THE SURROGATE ENDPOINT FOR A SURVIVAL TRUE ENDPOINT 387
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 383
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 378
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 366
Urinary Extracellular Vesicle Protein Profiles Discriminate Different Clinical Subgroups of Children with Idiopathic Nephrotic Syndrome 366
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 365
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 359
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 359
Validation of a skewed surrogate endpoint for a time-to-event outcome: the use of a Zaga distribution 353
Cytopathology of Bronchoalveolar Lavages in COVID-19 Pneumonia: A Pilot Study 349
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome 339
Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging 335
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19 334
Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases 329
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 322
Diagnostic performances of the acr-tirads system in thyroid nodules triage: A prospective single center study 320
Unsupervised neural networks as a support tool for pathology diagnosis in MALDI-MSI experiments: A case study on thyroid biopsies 319
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 315
Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies 315
Machine learning streamlines the morphometric characterization and multi-class segmentation of nuclei in different follicular thyroid lesions: everything in a NUTSHELL 314
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease 314
The role of comprehensive geriatric assessment and functional status in evaluating the patterns of antithrombotic use among older people with atrial fibrillation 314
Use of diagnostic criteria from acr and eu-tirads systems to improve the performance of cytology in thyroid nodule triage 311
Prevalence and timing of tracheostomy in traumatic brain injured patients: a secondary analysis from the CENTER-TBI study 309
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden 307
Effect of frailty on 6-month outcome after traumatic brain injury: a multicentre cohort study with external validation 307
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 306
Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T 305
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 304
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload 303
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation 297
Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis 297
Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study 297
Development of new methods for the validation of non standard distributions for the surrogate endpoint for a time to event endpoint. 288
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study 283
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study 283
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 278
Robust non parametric one-sample tests for the analysis of recurrent events 278
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 278
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability 277
Using multiple timescale models for the evaluation of a time-dependent treatment 277
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor 274
Overexpression of CXCR4 receptor on CD33.CAR-CIK cells enhances the control of the Acute Myeloid Leukemia burden 273
Neurological Pupil Index and Intracranial Hypertension in Patients with Acute Brain Injury: A Secondary Analysis of the ORANGE Study 272
Practice of ICP monitoring in acute brain‑injured patients: results from the Synapse‑ICU study 271
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome 269
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project 269
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave Dreams Study (Brain Venous Drainage Exploited Against Multiple Sclerosis): study protocol for a randomized controlled trial 269
Early systemic insults following traumatic brain injury: association with biomarker profiles, therapy for intracranial hypertension, and neurological outcomes-an analysis of CENTER-TBI data 265
Dissecting the histological features of lupus nephritis highlights new common patterns of injury in class III/IV 265
La qualita’ di vita nei pazienti neodializzati: due interventi di pre-dialisi a confronto 265
Prescribing patterns of antithrombotic drugs to elderly patients with atrial fibrillation admitted to an acute geriatric unit 265
MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer: a systematic review and meta-analysis 265
Iron Overload Following Hematopoietic Stem Cell Transplantation: Prevalence, Severity, and Management in Children and Adolescents with Malignant and Nonmalignant Diseases 263
Association between serum values of C-reactive protein and cytokine production in whole blood of patients with Type 2 diabetes 263
Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia 262
Microwave ablation of hepatic tumors with a third generation system: Loco-regional efficacy in a prospective cohort study with intermediate term follow-up 262
A causal inference approach to compare leukaemia treatment outcome in the absence of randomization and with dependent censoring 262
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML 259
Long-term effects of bone marrow transplantation on dental status in children with leukaemia 259
Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy 259
Carotid plaque echolucency predicts the effectiveness of brain protection devices in carotid stenting: The ICAROS study 258
Multiple sclerosis progression is not associated with birth timing in Italy 256
Overexpression of CXCR4 Enhances the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia 254
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 253
Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence 251
Intracranial pressure management in acute brain‑injured patients: baseline characteristics of the Synapse‑ICU Centers ESICM LIVES 2020 251
The Neurological Pupil index for outcome prognostication in people with acute brain injury (ORANGE): a prospective, observational, multicentre cohort study 250
Sample size calculation for recurrent events data in one-arm studies 247
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 247
Multivariate permutation test to compare survival curves for matched data 246
Percutaneous Microwave Ablation of Hepatic Tumors: Prospective Evaluation of Postablation Syndrome and Postprocedural Pain 243
Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response 242
Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation 241
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 241
Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions 239
Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission 239
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 239
An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID) 237
A DNA damage response-like phenotype defines a third of colon cancers at onset 236
Totale 34.123
Categoria #
all - tutte 146.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.644


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.053 0 226 254 246 169 163 71 83 116 179 191 355
2022/20233.651 417 972 374 333 207 507 69 233 271 38 147 83
2023/20242.829 90 122 113 202 330 653 551 122 173 72 95 306
2024/20257.045 282 592 566 368 609 410 390 268 697 1.073 608 1.182
2025/202621.972 2.481 1.389 1.379 2.115 2.164 1.025 2.819 853 1.529 3.472 1.241 1.505
2026/20272.016 1.259 757 0 0 0 0 0 0 0 0 0 0
Totale 48.767